CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 100,000 shares at an average $2.20 ($220,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SC 13D Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion CEO, ANHEART THERAPEUTICS LTD. acquired 4,239,300 shares (conversion)
- 8-K Event Shareholder vote results · Other events
- 4 Conversion Director acquired 19,004,200 shares (conversion)
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- DEFR14A Other DEFR14A
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 7 of 20 · 400 filings